La Jolla Pharma

XERAVA

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

La Jolla Pharma

Xerava HCPCS:

J0122

HCPCS Code Descriptor:

Injection, eravacycline, 1 mg

Category:

J Code

Xerava NDCs:

71773-0100-12, 71773-0050-05, 71773-0050-12

Primary Type:

Antibiotic

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Xerava CPT Codes:

Potential CPT administration codes for Xerava can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

71773-0100-12, 71773-0050-05, 71773-0050-12

About Xerava:

XERAVA is an Antibiotic drug manufactured by La Jolla Pharma and administered via the Intravenous route of administration. The J Code: J0122 is aligned to the drug XERAVA.

ACCESS PRICING AND MORE BY REGISTERING

J0122 Added Date:

October 1, 2019

J0122 Effective Date:

October 1, 2019

J0122 Termination Date:

HCPCS Active

Xerava billing and coding information can be found through La Jolla Pharma at the link below:
Our team did not identify a source for Xerava patient assistance information. Please reach out to our team if you feel that this is a mistake.
XERAVA prescribing information can be found at the link below:
Information regarding XERAVA’s side effects can be found at MedlinePlus